18 June 2013
Keywords: Melanoma treatments, Yervoy, Zelboraf, Roche, Bristol-Myers Squibb, Decision Resources
Article | 23 August 2012
In the USA and Europe there is strong physician desire for new therapies for the treatment of early stage melanoma, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 August 2012
24 August 2012
17 June 2013
© 2013 thepharmaletter.com